Michael A. Chambers's Insider Trades & SAST Disclosures

Michael A. Chambers's most recent trade in Sarepta Therapeutics Inc was a trade of 4,792 Stock Options (right to buy) done . Disclosure was reported to the exchange on March 10, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Sarepta Therapeutics Inc
Michael A. Chambers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 4,792 4,792 - - Stock Options (right to buy)
Sarepta Therapeutics Inc
Michael A. Chambers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 2,383 10,660 (0%) 0% - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades